Rivaroxaban Clinical Trials
Conditions / Rivaroxaban
Delta Trials catalogs 8 clinical trials for Rivaroxaban in its publicly accessible dataset. Within this set, 3 currently recruiting participants and 1 trial have reached completion. This research occurs across 16 participating sites around the world. An additional 4 trials are in other active phases such as not yet recruiting or pending status. All data is sourced directly from ClinicalTrials.gov and updated as trial registrations and statuses evolve over time.
Trial Status
8
Total Trials
3
Recruiting
1
Completed
4
Other Active
0
Terminated since 2020
16
Study Locations
Browse by location (16 total)
- Shanghai, China 4 trialsAll trials in Shanghai, China
- Chongqing, China 2 trialsAll trials in Chongqing, China
- Hefei, China 2 trialsAll trials in Hefei, China
- Beijing, China 2 trialsAll trials in Beijing, China
- Zhengzhou, China 2 trialsAll trials in Zhengzhou, China
- Nanchang, China 1 trialAll trials in Nanchang, China
- Qingdao, China 1 trialAll trials in Qingdao, China
- Wuxi, China 1 trialAll trials in Wuxi, China
- Fuzhou, China 1 trialAll trials in Fuzhou, China
- Changsha, China 1 trialAll trials in Changsha, China
- Hohhot, China 1 trialAll trials in Hohhot, China
- Santo André, Brazil 1 trialAll trials in Santo André, Brazil
- Santo André, Brazil 1 trialAll trials in Santo André, Brazil
- Shenyang, China 1 trialAll trials in Shenyang, China
- Philadelphia, United States 1 trialAll trials in Philadelphia, United States
- Seongnam, South Korea 1 trialAll trials in Seongnam, South Korea
- Seoul, South Korea 1 trialAll trials in Seoul, South Korea